Table 1. The clinical evaluation of EAE mice.
Group | n | Incidence ( % ) | Mean onset date | Mean score of maximal symptom |
EAE control | 13 | 100 | 12.38±1.45 | 2.62±1.08 |
Fasudil late | 13 | 76.9 | 13.50±2.17 | 1.41±1.08* |
Fasudil early | 13 | 23.1* | 18.00±3.61* | 0.30±0.72** |
Fasudil was injected (i.p.) at 40 mg/kg/d every other day on day 3 p.i. (Fasudil early treatment) and on day 11 p.i. (Fasudil late treatment). The injection of normal saline was set up as control (EAE control) in a similar manner. Data are presented as mean ± S.E.M.
p<0.05,
p<0.01.